125 related articles for article (PubMed ID: 9857225)
1. Endopeptidase 24.11/CD10 is down-regulated in renal cell cancer.
Göhring B; Holzhausen HJ; Meye A; Heynemann H; Rebmann U; Langner J; Riemann D
Int J Mol Med; 1998 Oct; 2(4):409-14. PubMed ID: 9857225
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.
Kehlen A; Göhring B; Langner J; Riemann D
Clin Exp Immunol; 1998 Feb; 111(2):435-41. PubMed ID: 9486416
[TBL] [Abstract][Full Text] [Related]
3. Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent.
Varona A; Blanco L; Perez I; Gil J; Irazusta J; López JI; Candenas ML; Pinto FM; Larrinaga G
BMC Cancer; 2010 May; 10():193. PubMed ID: 20459800
[TBL] [Abstract][Full Text] [Related]
4. Immunoelectron microscopic demonstration of the membrane proteases aminopeptidase N/CD13 and dipeptidyl peptidase IV/CD26 in normal and neoplastic renal parenchymal tissues and cells.
Stange T; Kettmann U; Holzhausen HJ
Eur J Histochem; 2000; 44(2):157-64. PubMed ID: 10968363
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD13/aminopeptidase N and CD10/neutral endopeptidase on cultured human keratinocytes.
Gabrilovac J; Cupić B; Breljak D; Zekusić M; Boranić M
Immunol Lett; 2004 Jan; 91(1):39-47. PubMed ID: 14757368
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13.
Riemann D; Kehlen A; Langner J
Clin Exp Immunol; 1995 May; 100(2):277-83. PubMed ID: 7743667
[TBL] [Abstract][Full Text] [Related]
8. Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma.
Varona A; Blanco L; López JI; Gil J; Agirregoitia E; Irazusta J; Larrinaga G
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F780-8. PubMed ID: 16985214
[TBL] [Abstract][Full Text] [Related]
9. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
[TBL] [Abstract][Full Text] [Related]
10. Acid, basic, and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma.
Blanco L; Larrinaga G; Pérez I; López JI; Gil J; Agirregoitia E; Varona A
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F850-8. PubMed ID: 18216146
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
12. [Expression of Ksp-cadherin in renal epithelial neoplasm and its clinicopathologic significance].
Rao Q; Zhou XJ; Shi QL; Yin HL; Ma HH; Zhou HB; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):15-8. PubMed ID: 17374232
[TBL] [Abstract][Full Text] [Related]
13. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
[TBL] [Abstract][Full Text] [Related]
14. The impact of peptidase activity on clear cell renal cell carcinoma survival.
Larrinaga G; Blanco L; Sanz B; Perez I; Gil J; Unda M; Andrés L; Casis L; López JI
Am J Physiol Renal Physiol; 2012 Dec; 303(12):F1584-91. PubMed ID: 23019229
[TBL] [Abstract][Full Text] [Related]
15. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
[TBL] [Abstract][Full Text] [Related]
16. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
Ozolek JA; Bastacky SI; Myers EN; Hunt JL
Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of SHP2, a protein-tyrosine phosphatase with SRC homology-2 domains, in various types of renal tumour.
Kuroda N; Hayashi Y; Matozaki T; Hanioka K; Gotoh A; Wang W; Uchida H; Hashimoto K; Iwai Y; Kawasaki K; Imai Y; Kasuga M; Itoh H
Virchows Arch; 1998 Oct; 433(4):331-9. PubMed ID: 9808435
[TBL] [Abstract][Full Text] [Related]
19. Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients.
Errarte P; Beitia M; Perez I; Manterola L; Lawrie CH; Solano-Iturri JD; Calvete-Candenas J; Unda M; López JI; Larrinaga G
PLoS One; 2017; 12(8):e0181711. PubMed ID: 28809959
[TBL] [Abstract][Full Text] [Related]
20. Immunoexpression of napsin A in renal neoplasms.
Zhu B; Rohan SM; Lin X
Diagn Pathol; 2015 Mar; 10():4. PubMed ID: 25889632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
